Jennifer Sweeney

3.9k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Jennifer Sweeney is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jennifer Sweeney has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Jennifer Sweeney's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Jennifer Sweeney is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (8 papers). Jennifer Sweeney collaborates with scholars based in United States, Australia and France. Jennifer Sweeney's co-authors include Christine Bechtel, Shoshanna Sofaer, Maureen Maurer, Kristin L. Carman, Pam Dardess, Karen Adams, Patrick Kelly, Kerstin Allen, Steven M. Horwitz and Ian W. Flinn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jennifer Sweeney

52 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patient And Family Engagement: A Framework For Understanding The Elements And Developing Interventions And Policies

2013 1.2k citations Jennifer Sweeney et al. profile →

Peers

Countries citing papers authored by Jennifer Sweeney

Since Specialization

Citations

This map shows the geographic impact of Jennifer Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Sweeney more than expected).

Fields of papers citing papers by Jennifer Sweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Sweeney. The network helps show where Jennifer Sweeney may publish in the future.

Co-authorship network of co-authors of Jennifer Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Sweeney. A scholar is included among the top collaborators of Jennifer Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Sweeney. Jennifer Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of hospital-onset bloodstream infections compared to central line...associated bloodstream infections at an acute, tertiary care hospital 2023 ·American Journal of Infection Control ·(unknown), (unknown), Jennifer Sweeney, (unknown), Laraine Washer	8
2	Pressure Injury Prevention for Complex Cardiovascular Patients in the Operating Room and Intensive Care Unit 2021 ·Journal of Wound Ostomy and Continence Nursing ·Joyce Pittman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer Sweeney	8
3	Incorporating preauthorization into antimicrobial stewardship pharmacist workflow reduces Clostridioides difficile and gastrointestinal panel testing 2020 ·Infection Control and Hospital Epidemiology ·(unknown), John Mills, Christopher Zimmerman, Tejal Gandhi, Alison C. Tribble, Lindsay A Petty, Jerod Nagel, (unknown), (unknown), Twisha S Patel, Nicholas O. Dillman, Randolph E. Regal, Kristin C. Klein, Laraine Washer, Vincent D. Marshall, Jennifer Sweeney, Krishna Rao, Gregory Eschenauer	9
4	Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study 2020 ·Journal of Vascular and Interventional Radiology ·(unknown), (unknown), Anupam Rishi, (unknown), Jessica M. Frakes, Junsung Choi, Ghassan El‐Haddad, Nainesh Parikh, Jennifer Sweeney, Béla Kis	6
5	Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in Patients with Relapsed or Refractory Hematologic Malignancies 2019 ·Blood ·Manish R. Patel, Guillermo Garcia‐Manero, Ronald Paquette, Shira Dinner, William B. Donnellan, Michael R. Grunwald, Maria Ribadeneira, Patricia Schroeder, Julie Brevard, Lindsey Wilson, Jennifer Sweeney, Patrick Kelly, Jeffrey E. Lancet	22
6	Strategies for the successful implementation of disinfecting port protectors to reduce CLABSI in a large tertiary care teaching hospital 2019 ·American Journal of Infection Control ·Cole Beeler, (unknown), (unknown), (unknown), (unknown), Kathleen Doyle Lyons, (unknown), Jennifer Sweeney, (unknown), (unknown), Douglas Webb	3
7	Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study 2018 ·Journal of Vascular and Interventional Radiology ·Alexandra Gangi, (unknown), (unknown), (unknown), Jennifer Sweeney, Junsung Choi, Ghassan El‐Haddad, (unknown), Nainesh Parikh, Bülent Arslan, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Daniel A. Anaya, Mokenge P. Malafa, Dung‐Tsa Chen, Yunyun Chen, Richard D. Kim, Ravi Shridhar, Béla Kis	56
8	FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study 2018 ·Blood ·Jörge E. Cortes, Justin M. Watts, Thomas Prébet, Gary J. Schiller, Sang‐Min Lee, Jay Yang, Eunice S. Wang, Shira Dinner, P. Brent Ferrell, Will Donnellan, Brian A. Jonas, Andrew H. Wei, Pau Montesinos, (unknown), Patrick Kelly, Ping Li, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, Maria R. Baer	14
9	Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization 2018 ·Journal of Gastrointestinal Oncology ·Jessica M. Frakes, Y.A. Abuodeh, A.O. Naghavi, Michelle Echevarria, Ravi Shridhar, Mark Friedman, Richard D. Kim, Ghassan El‐Haddad, Béla Kis, (unknown), Jennifer Sweeney, Junsung Choi, Daniel Anaya, Anna R. Giuliano, Sarah E. Hoffe	4
10	Inferior vena cava filter placement in a left IVC and drainage into duplicated SVC via hemiazygous continuation 2018 ·Radiology Case Reports ·Jennifer Sweeney, Nainesh Parikh	1
11	Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma 2018 ·Journal of Gastrointestinal Oncology ·Homan Mohammadi, Y.A. Abuodeh, (unknown), Jessica M. Frakes, Mark Friedman, (unknown), Junsung Choi, Ghassan El‐Haddad, Béla Kis, Jennifer Sweeney, Sarah E. Hoffe	29
12	Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical activity in indolent non‐Hodgkin lymphoma in a phase 1 study 2018 ·American Journal of Hematology ·Ian W. Flinn, Manish R. Patel, Yasuhiro Oki, Steven M. Horwitz, (unknown), Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, (unknown), Patrick Kelly, Virginia Kelly, Brad S. Kahl	26
13	Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies 2017 ·Blood ·Ian W. Flinn, Susan O’Brien, Brad S. Kahl, Manish R. Patel, Yasuhiro Oki, (unknown), Pierluigi Porcu, Jeffrey A. Jones, Jan A. Burger, Nitin Jain, Virginia Kelly, Kerstin Allen, Mark Douglas, Jennifer Sweeney, Patrick Kelly, Steven M. Horwitz	183
14	Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma 2017 ·Blood ·Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison J. Moskowitz, Megan N. Perez, Patricia L. Myskowski, Adam Officer, Jacob D. Jaffe, Sara Morrow, Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David T. Weaver, Francine M. Foss, David M. Weinstock	204
15	Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization 2016 ·World Journal of Gastroenterology ·Y.A. Abuodeh, A.O. Naghavi, Kamran A. Ahmed, Puja Venkat, Youngchul Kim, Béla Kis, Junsung Choi, (unknown), Jennifer Sweeney, Daniel A. Anaya, Richard D. Kim, Mokenge P. Malafa, Jessica M. Frakes, Sarah E. Hoffe, Ghassan El‐Haddad	16
16	Outcomes of Therasphere Radioembolization for Colorectal Metastases 2015 ·Clinical Colorectal Cancer ·Andrea M. Abbott, Richard D. Kim, Sarah E. Hoffe, Bülent Arslan, (unknown), Junsung Choi, Ghassan El‐Haddad, Béla Kis, Jennifer Sweeney, Kenneth Meredith, Khaldoun Almhanna, Jonathan Strosberg, David Shibata, William J. Fulp, Ravi Shridhar	25
17	Serum chemokines and cytokines in CLL patients treated with duvelisib, a PI3K-δ,γ inhibitor. 2015 ·Journal of Clinical Oncology ·Mark Douglas, Kerstin Allen, Jennifer Sweeney, Susan O’Brien, Ian W. Flinn, Steven M. Horwitz, John C. Byrd, Manish R. Patel, Brad S. Kahl, Francine M. Foss, Pierluigi Porcu, Virginia Kelly, Howard M. Stern	2
18	Mass Transfusion to Combat Trauma's Lethal Triad 2012 ·Journal of Emergency Nursing ·Jennifer Sweeney	2
19	Phase I/II trial of the novel Hsp90 inhibitor, IPI-504, in patients with relapsed and/or refractory stage IIIB or stage IV non-small cell lung cancer stratified by EGFR mutation status 2007 ·Molecular Cancer Therapeutics ·Lecia V. Sequist, Pasi A. Jänne, John R. Walker, Jennifer Sweeney, David Grayzel, Thomas J. Lynch	14
20	Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability 2003 ·Kidney International ·William E. Sweeney, Kiyoshi Hamahira, Jennifer Sweeney, (unknown), Philip Frost, Ellis D. Avner	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact